Curcumin, which exists in the rhizomes of Curcuma longa, has been approved for the treatment of CRC (109, 110), and it can inhibit tumor occurrence by inducing the expression of a suppressor lncRNA neighbor of BRCA1 gene 2 (NBR2). This evidence concerns the gene NBR2 and neoplasm.